The analytical method for a confirmatory drug test must combine chromatographic separation and mass spectrometric identification (i.e. GC/MS, LC/MS) for ten (10) categories of drugs will be required with the following cut-off limits:
| Amphetamines |
500
|
250 |
MDMA (Ecstasy)
|
500 |
250 |
| Barbiturates |
300
|
300
|
| Benzoylecgonine (Cocaine) |
150 |
100 |
Cannabinoids (THC-Pot)
|
50
|
15
|
| Opiates |
2000
|
2000
|
(Oxycodone)
|
100 |
100
|
(Hydromorphone)
|
300
|
300 |
(Hydrocodone)
|
300
|
300
|
(6-Acetylmorphine) (Heroin)
|
10
|
10
|
| Phencyclidine (PCP) |
25 |
25
|
| Benzodiazepines |
300 |
300
|
| Methadone |
300 |
300
|
| Propoxyphene |
300
|
300
|
Cut off limits established by the Department of Health and Human Services in their mandatory Guidelines for Federal Workplace Drug Testing Programs and/or standard general industry practices.
All screening and analysis will be performed by a SAMHSA Certified Independent Testing Laboratory selected by LEAD which meets the requirements of number paragraph 3 of the Introduction. The Certified Laboratory shall be responsible for implementing the drug screening test and shall report all results to the Medical Review Officer (MRO) to perform the duties hereafter set forth.